Compare SWMR & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SWMR | ANGO |
|---|---|---|
| Founded | 2023 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 453.1M | 420.2M |
| IPO Year | 2026 | 2004 |
| Metric | SWMR | ANGO |
|---|---|---|
| Price | $39.96 | $15.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 271.3K | ★ 433.9K |
| Earning Date | 05-20-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | $2,862.05 | $9.51 |
| Revenue Next Year | $177.93 | $4.96 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $25.75 | $9.39 |
| 52 Week High | $83.30 | $16.29 |
| Indicator | SWMR | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 48.09 | 61.99 |
| Support Level | $35.28 | $10.56 |
| Resistance Level | $47.26 | $16.11 |
| Average True Range (ATR) | 4.03 | 0.47 |
| MACD | 0.48 | -0.07 |
| Stochastic Oscillator | 34.99 | 55.14 |
Swarmer Inc is a provider of autonomous drone swarm software and AI solutions, specializing in vendor-agnostic technologies. It develops software platforms and artificial intelligence systems for defence applications, enabling military organisations to deploy and coordinate large-scale unmanned and autonomous systems. Its offerings include swarm coordination software, multi-domain unmanned systems integration, collaborative autonomy solutions, and command-and-control software for distributed robotic operations. Its key software and AI systems include: i) STYX AI Command & Control System, ii) MINAS Autonomy and Collaboration AI and iii) TRIDENT Embedded Drone Operating System. The company generates revenue through software license sales.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.